Doctors in Germany have for the first time, successfully treated twins in utero using a biotech drug, pointing to a new way to eliminate disease.
Less than half the patients diagnosed with cancer respond favourably to chemotherapy. Now, a new method for testing how patients will respond to various drugs could pave the way for more personalised treatment.
Researchers have been developing CRISPR gene editing as a potential therapeutic tool for years, but now they have turned their attention to using it in cancer diagnostics.
A team of scientists at GRAIL has announced progression towards the goal of a simple blood test being able to detect a small tumour growing in your body.
A group of Africa-based researchers has issued guidelines for the ethical handling of samples for genomic studies, in an effort to combat ‘helicopter’ research.
For the first time, a human mini brain has been implanted into the skull of mice and surprisingly has continued to grow.
A new study published in the journal Nature Biotechnology brings us closer to a complete genetic blueprint by using a nanotechnology-based sequencing technique.
French CAR-T specialist Cellectis didn’t have the best time in 2017, but it seems their luck is changing, having just closed a $164 million U.S. public offering.
Studies using CRISPR on monkeys look encouraging, but more needs to be done before the gene-editing technology can be used on humans.